PBH
Prestige Consumer Healthcare Inc.Healthcare · $2.2B market cap
Verdict
Share price
$45.26
close of Oct 3, 2026
Fair value
$37.39
Sticker Price
Payback Price
$14.96
buy price
PBH is Overpriced: at $45.26 it trades 21% above its fair value of $37.39. Its buy price (Payback Price) is $14.96, 67% below today's price. Business quality is mixed: 2 of 5 key numbers clear the 10% bar.
How we valued it
Free Cash Flow. Sales grew -1% a year over the last 3 years, below the 15% we look for in a fast grower, so we value it on its free cash flow instead of an earnings forecast.
Business quality
2 of 5 clear the 10% bar. What are the Big Five?
Follow PBH
Get notified when it reaches its buy price of $14.96. Free.
Create a free accountSuperinvestors
2 of the investors we track hold PBH. In Q2 2026, 1 opened a position and 1 added. Who we track
Insider activity
Since Aug 4, 2026: no open-market purchases and 5 other filings (stock awards, tax withholding and similar). Why purchases matter
Other filings
About Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare Inc., along with its various divisions, is involved in the creation, production, promotion, and distribution of non-prescription health and personal care items across both domestic (U.S.) and global markets. The company's business activities are structured into two principal areas: North American Over-the-Counter Healthcare and International Over-the-Counter Healthcare. Their extensive…
Medical - Pharmaceuticals
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works